Germany Home to Europe’s largest pharma market, a host of industry giants, a thriving biotech scene, and a public healthcare system undergoing significant reform, Germany is indisputably one of the world’s most important life science nations.   An overview of the pharma industry in Germany. Made with Visme Infographic Maker   The…

LatAm A breakdown of the investments made by the pharmaceutical industry in clinical studies across the Latin American region. According to the US National Library of Medicine’s ClinicalTrials.gov, USD 1.1 billion were invested in 2019 with Mexico, Brazil and Argentina at the head of the LatAm countries where these investments were…

LatAm As selected by the Generics & Biosimilars Initiative (GABI), these are the top ten pharma companies ranked by turnover in Argentina, Brazil, Chile, Colombia, and Mexico for 2021. As the chart shows, the Argentinian and Brazilian Top Tens are dominated by domestic companies, while multinationals hold sway in Colombia and…

Greece A pharma market snapshot of Greece, a country whose life expectancy ranks well above the European Union member states’ average. Greece also boasts a relatively high pharmaceutical expenditure compared to its European neighbors and has seen pharmaceutical sales, led by exports, grow exponentially in recent years.   Total Pharmaceutical Expenditure…

China The top 10 Chinese pharma companies for 2022, ranked by sales value and based on data from the latest Forbes Global 2000 ranking. Big conglomerates like Sinopharm, Shanghai Pharmaceuticals, and Jointown dominate the list, while other national champions in the midst of expanding their innovation efforts like Jiangsu Hengrui and…

Middle East & Africa Apart from a maturing regulatory environment and the expansion of healthcare coverage across the region, a number of other factors are contributing to the evolution of the MEA pharma market. Results from the second wave of a PhRMA-commisioned IQVIA market access study covering Saudi Arabia (KSA), UAE, Kuwait, Lebanon, Jordan,…

Middle East & Africa Within the context of the MEA region’s maturing regulatory environment, the expansion of healthcare coverage and regulatory changes aimed at making the New Molecular Entities (NMEs) review process more efficient, registrations have increased in Saudi Arabia, UAE, Tunisia and Egypt, but slowed down in other territories. Results from the second…

Middle East & Africa Most of the Middle East & Africa’s largest markets continue to grow, but Saudi Arabia remains at the top with the region’s largest pharma market, valued at USD 8.5 billion.   Hecho conVisme Infographic Maker   See the complete set of Saudi Arabia Facts & Figures from PharmaBoardroom’s Healthcare &…

Taiwan With a healthcare system that is emerging as one of the most advanced in Asia and legislation that aims to support the biomedical industry, Taiwan’s pharma, biotech and medical devices markets have seen steady growth in recent years. Hecho conVisme Infographic Maker Hecho conVisme Infographic Maker Hecho conVisme Infographic Maker…

Algeria A snapshot of Algeria, one of the key countries driving growth in MENA, a region that accounts for just 2 percent of world’s pharma market but that is estimated to reach around USD 60 billion by 2025. Algeria has steadily improved its essential health care services. Hecho conVisme Infographic Maker…

Australia With one of the best healthcare systems in the world, according to the World Health Organisation (WHO), Australia is home to some 250 global and local reasearch-based pharmaceutical companies and ranks 13th in the global share of pharmaceutical patents. Value of the market: Economic footprint of the industry: Acquistions of…

Americas A snapshot of Argentina, one of the Latin American markets featured in PharmaBoardroom’s report, InFigures: Latin America 2022. Within the regional market of USD 98 billion, which looks set to be the fastest growing in the world over the next few years, Argentina is one of the largest markets. Behind…